140 related articles for article (PubMed ID: 8641740)
1. Sodium-lithium countertransport and blood pressure change over time: the Gubbio study.
Cirillo M; Laurenzi M; Panarelli W; Trevisan M; Dyer AR; Stamler R; Stamler J
Hypertension; 1996 Jun; 27(6):1305-11. PubMed ID: 8641740
[TBL] [Abstract][Full Text] [Related]
2. Baseline sodium-lithium countertransport and 6-year incidence of hypertension. The Gubbio Population Study.
Laurenzi M; Cirillo M; Panarelli W; Trevisan M; Stamler R; Dyer AR; Stamler J
Circulation; 1997 Feb; 95(3):581-7. PubMed ID: 9024143
[TBL] [Abstract][Full Text] [Related]
3. Prospective analysis of traits related to 6-year change in sodium-lithium countertransport. Gubbio Population Study Research Group.
Cirillo M; Laurenzi M; Panarelli W; Trevisan M; Stamler J
Hypertension; 1999 Mar; 33(3):887-93. PubMed ID: 10082504
[TBL] [Abstract][Full Text] [Related]
4. Correlates of sodium-lithium countertransport. Findings from the Gubbio Epidemiological Study. The Gubbio Collaborative Study Group.
Trevisan M; Laurenzi M
Circulation; 1991 Nov; 84(5):2011-9. PubMed ID: 1934375
[TBL] [Abstract][Full Text] [Related]
5. Sodium-lithium countertransport and blood pressure: the Gubbio Population Study.
Laurenzi M; Trevisan M
Hypertension; 1989 May; 13(5):408-15. PubMed ID: 2722223
[TBL] [Abstract][Full Text] [Related]
6. Red blood cell sodium-lithium countertransport and risk of future hypertension: the Olivetti Prospective Heart Study.
Strazzullo P; Siani A; Cappuccio FP; Trevisan M; Ragone E; Russo L; Iacone R; Farinaro E
Hypertension; 1998 Jun; 31(6):1284-9. PubMed ID: 9622143
[TBL] [Abstract][Full Text] [Related]
7. The Gubbio data. Epidemiology and pathophysiology. Gubbio Study Research Group.
Laurenzi M; Cirillo M; Trevisan M
Clin Exp Hypertens A; 1992; 14(1-2):261-9. PubMed ID: 1541040
[TBL] [Abstract][Full Text] [Related]
8. Increased sodium-lithium countertransport activity in red cells of IgA nephropathy patients.
Boero R; Degli Esposti E; Fabbri A; Guarena C; Forneris G; Quarello F; Fusaroli M; Piccoli G
Kidney Int; 1991 Dec; 40(6):1118-22. PubMed ID: 1762312
[TBL] [Abstract][Full Text] [Related]
9. Changes in sodium-lithium countertransport correlate with changes in triglyceride levels and body mass index over 2 1/2 years of follow-up in Utah.
Hunt SC; Williams RR; Ash KO
Cardiovasc Drugs Ther; 1990 Mar; 4 Suppl 2():357-62. PubMed ID: 2271398
[TBL] [Abstract][Full Text] [Related]
10. The relationship of erythrocyte sodium-lithium countertransport to blood pressure and metabolic abnormalities in a sample of untreated middle-aged male workers.
Strazzullo P; Cappuccio FP; Trevisan M; Siani A; Barba G; Ragone E; Pagano E; Mancini M
J Hypertens; 1993 Aug; 11(8):815-22. PubMed ID: 8228205
[TBL] [Abstract][Full Text] [Related]
11. Baseline Na-Li countertransport and risk of hypertension in children: a 10-year prospective study in Hanzhong children.
Mu J; Liu Z; Yang D; Liang Y; Wang Z; Hou R
J Hum Hypertens; 2004 Dec; 18(12):885-90. PubMed ID: 15269707
[TBL] [Abstract][Full Text] [Related]
12. Nonlinear relationship between erythrocyte sodium-lithium countertransport and blood pressure in man.
Petrov VV; Britov AN; Levitsky DO; Minchenko BI; Konstantinov EN; Svidersky VD; Novikov ID; Grishenkov EA; Lijnen PJ
Methods Find Exp Clin Pharmacol; 1994 Nov; 16(9):661-6. PubMed ID: 7746028
[TBL] [Abstract][Full Text] [Related]
13. Effects of atorvastatin on red-blood cell Na(+)/Li(+) countertransport in hyperlipidemic patients with and without hypertension.
Kosmidou MS; Hatzitolios AI; Adamidou A; Giannopoulos S; Raikos N; Parharidis G; Milionis HJ
Am J Hypertens; 2008 Mar; 21(3):303-9. PubMed ID: 18202666
[TBL] [Abstract][Full Text] [Related]
14. Red blood cell Li+-Na+ countertransport, Na+-K+ cotransport, and the hemodynamics of hypertension.
Weder AB; Fitzpatrick MA; Torretti BA; Hinderliter AL; Egan BM; Julius S
Hypertension; 1987 May; 9(5):459-66. PubMed ID: 3570422
[TBL] [Abstract][Full Text] [Related]
15. Sodium lithium countertransport and blood pressure. Longitudinal findings.
Trevisan M; Strazzullo P; Cappuccio F; Jossa F; Iacone R; Russo I; Farinaro E
Am J Hypertens; 1996 Nov; 9(11):1132-5. PubMed ID: 8931840
[TBL] [Abstract][Full Text] [Related]
16. Sodium-lithium countertransport in ambulatory hypertensive and normotensive patients.
Turner ST; Boerwinkle E; Johnson M; Richelson E; Sing CF
Hypertension; 1987 Jan; 9(1):24-34. PubMed ID: 2432010
[TBL] [Abstract][Full Text] [Related]
17. Elevated sodium-lithium countertransport activity in erythrocytes is predictive of the development of microalbuminuria in IDDM.
Monciotti CG; Semplicini A; Morocutti A; Maioli M; Cipollina MR; Barzon I; Palaro C; Brocco E; Trevisan M; Fioretto P; Crepaldi G; Nosadini R
Diabetologia; 1997 Jun; 40(6):654-61. PubMed ID: 9222644
[TBL] [Abstract][Full Text] [Related]
18. Ethnic differences in red blood cell sodium/lithium countertransport and metabolic correlates of hypertension: an international collaborative study.
Ragone E; Strazzullo P; Siani A; Iacone R; Russo L; Sacchi A; Cipriano P; Mancini M; Zhao G; Yuan XY; Li DY; Gong L
Am J Hypertens; 1998 Aug; 11(8 Pt 1):935-41. PubMed ID: 9715785
[TBL] [Abstract][Full Text] [Related]
19. Sodium-lithium countertransport activity in red blood cells of patients with IgA nephropathy.
Boero R; Fabbri A; Degli Esposti E; Guarena C; Forneris G; Lucatello A; Sturani A; Quarello F; Fusaroli M; Piccoli G
Am J Kidney Dis; 1993 May; 21(5 Suppl 2):61-5. PubMed ID: 8494021
[TBL] [Abstract][Full Text] [Related]
20. Enhanced Na-Li countertransport: a marker of inherited susceptibility to type 2 diabetes.
Vaccaro O; Cuomo V; Trevisan M; Cirillo M; Panarelli W; Laurenzi M; Mancini M; Riccardi G;
Int J Epidemiol; 2005 Oct; 34(5):1123-8. PubMed ID: 16087689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
